GLP‐1RA vs placebo
Heart failure hospitalisation (RR) · CVD (ASCVD, HF, or both)
GLP‐1RA showed no clear difference in hospitalisation for HF compared with placebo (high certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 0.95 [0.85, 1.06]6 studies · 36930 participantsHigh